127 related articles for article (PubMed ID: 38507991)
1. Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma.
Dal Lago EA; Sousa LG; Yang Z; Hoff CO; Bonini F; Sawyer M; Wang K; Lewis W; Wahid KA; Hanna EY; El-Naggar A; Fuller CD; Kundu S; Godoy M; Ferrarotto R
Oral Oncol; 2024 Apr; 151():106759. PubMed ID: 38507991
[TBL] [Abstract][Full Text] [Related]
2. Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
Kim JK; Kim HD; Jun MJ; Yun SC; Shim JH; Lee HC; Lee D; An J; Lim YS; Chung YH; Lee YS; Kim KM
Dig Dis Sci; 2017 Oct; 62(10):2923-2931. PubMed ID: 28815349
[TBL] [Abstract][Full Text] [Related]
3. Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary gland.
Umeda M; Nishimatsu N; Masago H; Ishida Y; Yokoo S; Fujioka M; Shibuya Y; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Oct; 88(4):473-8. PubMed ID: 10519758
[TBL] [Abstract][Full Text] [Related]
4. Determining Whether Tumor Volume Doubling Time and Growth Rate Can Predict Malignancy After Delayed Diagnostic Surgery of Follicular Neoplasm.
Kim M; Chung SR; Jeon MJ; Han M; Lee JH; Song DE; Baek JH; Kim TY; Kim WB; Shong YK; Kim WG
Thyroid; 2019 Oct; 29(10):1418-1424. PubMed ID: 31375058
[No Abstract] [Full Text] [Related]
5. Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
Fukuda N; Fujiwara Y; Wang X; Ohmoto A; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Takahashi S
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3037-3043. PubMed ID: 33219858
[TBL] [Abstract][Full Text] [Related]
6. Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
Yeh T; Yeung M; Sherman EJ; Tuttle RM; Sabra MM
Thyroid; 2020 Aug; 30(8):1112-1119. PubMed ID: 32131709
[No Abstract] [Full Text] [Related]
7. Efficacy of cyclophosphamide, doxorubicin, and cisplatin for adenoid cystic carcinoma, and their relationship with the pre-chemotherapy tumor growth rate.
Ha H; Keam B; Ock CY; Heo DS
Chin Clin Oncol; 2020 Apr; 9(2):15. PubMed ID: 32366107
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment quantitative
Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z
Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429
[TBL] [Abstract][Full Text] [Related]
9. Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.
van Weert S; Reinhard R; Bloemena E; Buter J; Witte BI; Vergeer MR; Leemans CR
Head Neck; 2017 Mar; 39(3):456-463. PubMed ID: 27775851
[TBL] [Abstract][Full Text] [Related]
10. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
11. [Survival Analysis of 76 Cases of Head and Neck Adenoid Cystic Carcinoma
with Lung Metastasis].
Yu Z; Yu L; Chen X; Yang X; Zhang B; Yu T; Du X
Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):412-419. PubMed ID: 34157801
[TBL] [Abstract][Full Text] [Related]
12. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.
Nathani P; Gopal P; Rich N; Yopp A; Yokoo T; John B; Marrero J; Parikh N; Singal AG
Gut; 2021 Feb; 70(2):401-407. PubMed ID: 32398224
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological features and prognostic factors of primary pulmonary adenoid cystic carcinoma: a study of 59 cases].
Han J; Gao XZ; Wei JG; Xie YL; Liu YQ; Li WC; Li SL
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):204-208. PubMed ID: 30831646
[No Abstract] [Full Text] [Related]
15. A population study comparing tracheal and lung adenoid cystic carcinoma.
Gu Y; Lai S; Wang Y; Yang J; Zhou P; Chen T
Cancer Med; 2024 Apr; 13(7):e7158. PubMed ID: 38572933
[TBL] [Abstract][Full Text] [Related]
16. Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement.
Liu Z; Fang Z; Dai T; Zhang C; Sun J; He Y
J Craniomaxillofac Surg; 2015 Jul; 43(6):751-7. PubMed ID: 25958766
[TBL] [Abstract][Full Text] [Related]
17. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Kim TY; Lee JH; Kim WB; Shong YK; Chung KW; Baek JH; Kim WG
Thyroid; 2019 May; 29(5):642-649. PubMed ID: 30864894
[No Abstract] [Full Text] [Related]
18. [The clinicopathological features and curative effect of the bronchoscopic interventional therapy combined with radiotherapy for the treatment of locally recurrent lung adenoid cystic carcinoma].
Zhu DC; Xu JH; Zhang MH; Zhu HX; Zhang Y; Zhang T; Xu GR
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):864-868. PubMed ID: 30481940
[No Abstract] [Full Text] [Related]
19. Correlation Factors Analysis of Breast Cancer Tumor Volume Doubling Time Measured by 3D-Ultrasound.
Zhang S; Ding Y; Zhou Q; Wang C; Wu P; Dong J
Med Sci Monit; 2017 Jun; 23():3147-3153. PubMed ID: 28652562
[TBL] [Abstract][Full Text] [Related]
20. [(18)F-fluorodeoxy glucose positron emission tomography/computed tomography manifestation and clinical characteristics of primary salivary gland-type lung cancer].
Ding CY; Li YY; Sun J; Guo Z; Li TR
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):288-293. PubMed ID: 31014054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
